N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patients

What Was Tested

This observational study paper looks at BNP (Nesiritide).

Therefore, the aim of their study was to examine the synergistic prognostic potential of NT-proBNP and high-sensitivity TnT (hs)TnT in unselected critically ill patients.

Why It Was Studied

Patients treated at medical intensive care units suffer from various pathologies and often present with elevated troponin T (TnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels.

Both markers may reflect different forms of cardiac involvement in critical illness.

Who Took Part

The age groups tagged for this paper are middle-aged adults and older adults, both men and women.

The researchers included all consecutive patients admitted to their intensive care unit within one year, excluding those suffering from acute myocardial infarction or undergoing cardiac surgery and measured NT-proBNP and TnT plasma levels on the day of admission and 72 hours thereafter.

How the Study Was Run

The timeline in the abstract includes one year.

What Was Measured

Patients treated at medical intensive care units suffer from various pathologies and often present with elevated troponin T (TnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels.

The subject headings attached to it are Austria, Biomarkers, Critical Illness, Incidence, Myocardial Infarction, Natriuretic Peptide, Brain and Peptide Fragments.

Author keywords: NT-proBNP, Troponin and type-2 myocardial infarction.

What This Means in Plain Language

This is a observational study of BNP (Nesiritide) over one year.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (European heart journal. Acute cardiovascular care), a journal based in England.

More context: the BNP (Nesiritide) compound page, all human trials.